Castle Biosciences, Inc. (NASDAQ:CSTL) Q2 2024 Earnings Call Transcript August 5, 2024
Castle Biosciences, Inc. beats earnings expectations. Reported EPS is $0.3104, expectations were $-0.16.
Operator: Good afternoon, and welcome to Castle Biosciences Second Quarter 2024 Conference Call. As a remainder, today’s call is being recorded. We will begin today’s call with opening remarks and introductions, followed by a question-and-answer session. I would like to turn the call over to Camilla...
